Kyverna's CEO on B-cell depletion and CD19 CAR-T for autoimmune conditions
- blonca9
- Mar 27, 2024
- 1 min read
Peter Maag describes how Kyverna has been focused on this area for five years and today has clinical experience in diseases as varied as lupus and multiple sclerosis.